ALK-Abelló A/S (AKBLF) News Today → Will this $2 AI stock double overnight? (From Behind the Markets) (Ad) Free AKBLF Stock Alerts $17.90 0.00 (0.00%) (As of 04/24/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartHeadlinesStock AnalysisAnalyst ForecastsChartHeadlines All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineInvitation to the presentation of ALK’s first quarter results on Friday 3 May 2024finance.yahoo.com - April 24 at 4:56 PMALK-Abelló A/S (OTC:AKBLF) Trading Down 4%americanbankingnews.com - April 20 at 2:11 AMAlaska Air Gr Stock (NYSE:ALK), Quotes and News Summarybenzinga.com - April 18 at 11:02 PMSave the date for ALK’s Capital Markets Day on 4 June 2024finance.yahoo.com - March 27 at 6:34 AMAnnual General Meeting in ALK-Abelló A/S held on 14 March 2024finance.yahoo.com - March 14 at 4:10 PMAnnual General Meeting in ALK-Abelló A/S on 14 March 2024finance.yahoo.com - February 16 at 9:38 AMALK Abello: Annual report 2023: ALK delivers 9% sales growth with profits up 50%finanznachrichten.de - February 8 at 8:50 AMALK Abello: ALK and McMaster researchers discover new cell that remembers allergiesfinanznachrichten.de - February 8 at 8:50 AMAnnual report 2023: ALK delivers 9% sales growth with profits up 50%finance.yahoo.com - February 8 at 8:50 AMALK and McMaster researchers discover new cell that remembers allergiesfinance.yahoo.com - February 7 at 5:38 PMALK’s 2030 CO2 reduction targets have been approved by SBTifinance.yahoo.com - February 5 at 8:07 AMRelease date of annual report 2023 for ALK and webcastfinance.yahoo.com - January 31 at 5:46 AMALK’s European registration application for house dust mite SLIT-tablet in young children accepted for reviewfinance.yahoo.com - January 25 at 10:57 AMALK completes first part of phase 1 trial with peanut SLIT-tabletfinance.yahoo.com - January 18 at 4:03 PMALK Abello: ALK to become sole manufacturer and distributor of skin antigen test for penicillin allergyfinanznachrichten.de - January 4 at 2:28 PMALK to Become Sole Manufacturer and Distributor of Skin Antigen Test for Penicillin Allergyfinance.yahoo.com - January 4 at 9:28 AMALK-Abello B (0OIR)uk.investing.com - December 21 at 8:35 PMALK – Financial calendar for the 2024 financial yearfinance.yahoo.com - December 20 at 7:26 AMALK Abello: ALK expands partnership with Torii in Japanfinanznachrichten.de - December 12 at 12:16 PMALK expands partnership with Torii in Japanfinance.yahoo.com - December 12 at 12:16 PMNine-month interim report (Q3) 2023finance.yahoo.com - November 15 at 1:55 AMAlk-Abello A/S Class B ALK Bmorningstar.com - November 9 at 1:36 PMRelease date of nine-month interim report (Q3) 2023 for ALK and audio castfinance.yahoo.com - November 9 at 8:36 AMALK-Abelló A/S (ALK-B.CO)finance.yahoo.com - October 16 at 10:32 AMALK-Abello: Promising Strides in Tree Pollen Allergy Vaccine for Childrenmsn.com - October 11 at 6:41 PMLarge Phase 3 clinical trial successfully meets primary endpoint, confirming the potential of ALK’s tree tablet in childrenfinance.yahoo.com - October 11 at 1:06 PMALK-Abello B (ALKb)investing.com - August 26 at 2:08 AMSix-month interim report (Q2) 2023finance.yahoo.com - August 24 at 2:00 AMRelease date of six-month interim report (Q2) 2023 for ALK and audio castfinance.yahoo.com - August 18 at 7:10 AMPresident & CEO Carsten Hellmann to step down end 2023. Peter Halling appointed as his successorfinance.yahoo.com - June 19 at 7:57 AMLarge Phase 3 clinical trial successfully meets primary endpoint, confirming the potential of ALK’s house dust mite tablet in young childrenfinance.yahoo.com - June 8 at 1:11 PMALK-Abelló A/S reports Q1 resultsmsn.com - May 9 at 11:56 AMThree-month interim report (Q1) 2023finance.yahoo.com - May 9 at 6:54 AMRelease date of three-month interim report (Q1) 2023 for ALK and audio castfinance.yahoo.com - May 1 at 7:14 AMALK announces preliminary Q1 figures and confirms its full-year revenue and earnings outlookfinance.yahoo.com - April 17 at 3:33 PMGrant of share-based long-term incentive instruments to members of the Board of Management and key employeesfinance.yahoo.com - March 31 at 1:35 PMAnnual General Meeting in ALK-Abelló A/S held on 23 March 2023finance.yahoo.com - March 23 at 2:09 PMGuru Fundamental Report for ALKnasdaq.com - March 18 at 12:42 PMAnnual General Meeting in ALK on 23 March 2023finance.yahoo.com - February 27 at 7:29 AMALK appoints Claus Steensen Sølje as new Chief Financial Officer (CFO)finance.yahoo.com - February 10 at 9:50 AMALK Abello: Annual report 2022: ALK delivers sales growth of 13% with profits up 33% in 2022finanznachrichten.de - February 3 at 2:53 PMAnnual report 2022: ALK delivers sales growth of 13% with profits up 33% in 2022finance.yahoo.com - February 3 at 9:52 AMRegulatory filing for house dust mite allergy tablet accepted for review in Chinafinance.yahoo.com - February 3 at 9:52 AMRelease date of annual report 2022 for ALK and audio castfinance.yahoo.com - January 27 at 9:47 AMU.S. FDA Approves ALK's ODACTRA® (House Dust Mite Allergen Extract) Tablet for Sublingual Use as Immunotherapy for Adolescentsfinance.yahoo.com - January 25 at 9:14 AMHenriette Mersebach to succeed Henrik Jacobi as Executive Vice President, R&D at ALKfinance.yahoo.com - December 21 at 8:16 AMALK – Financial calendar for the 2023 financial yearfinance.yahoo.com - December 19 at 1:52 PMManagement change at ALKfinance.yahoo.com - November 30 at 3:44 PMNine-month interim report (Q3) 2022finance.yahoo.com - November 10 at 4:44 AMRelease date of nine-month interim report (Q3) 2022 for ALK and audio castfinance.yahoo.com - November 3 at 11:09 AM Get ALK-Abelló A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for AKBLF and its competitors with MarketBeat's FREE daily newsletter. Email Address Urgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It! (Ad)The FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st This guide shows you what to do next. In a cashless society, Biden forces you to use the government's new "digital dollar"... CLICK HERE TO GET YOUR GUIDE NOW AKBLF Media Mentions By Week AKBLF Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AKBLF News Sentiment▼0.390.44▲Average Medical News Sentiment AKBLF News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AKBLF Articles This Week▼30▲AKBLF Articles Average Week Get ALK-Abelló A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for AKBLF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AGNPF News Today DRTSW News Today ARNI News Today ARTLW News Today ASCLF News Today AWKNF News Today AXIM News Today BRRGF News Today BCTXW News Today CLVLY News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTC:AKBLF) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry Research1970’s computer coder issues shocking A.I. warningTradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ALK-Abelló A/S Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
